Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Blankenstein, Thomas Prof. Dr. (17) Daumke, Oliver Prof. Dr. (1) Hinz, Michael Dr. (2) Kammertöns, Thomas Dr. (4) Kopp, Joachim Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (10) Pezzutto, Antonio Prof. Dr. (1) Rocks, Oliver Dr. (1) Scheidereit, Claus Prof. Dr. (4) Uckert, Wolfgang Prof. Dr. (1) Willimsky, Gerald Dr. (6) Wollert-Wulf, Brigitte (4) (-) Daniel, Peter Prof. Dr. (2) (-) Janz, Martin Dr. (6) (-) Leisegang, Matthias Prof. Dr. rer. nat. (1) (-) Biologie maligner Lymphome (6) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Mathematische Modellierung zellulärer Prozesse (1) (-) Molekulare Immunologie und Gentherapie (2) Proteom Dynamik (9) Translationale Onkologie solider Tumore (1) (-) 2002 (1) 2003 (3) 2004 (2) 2005 (3) (-) 2006 (5) 2007 (3) 2008 (2) 2009 (3) 2010 (2) 2011 (6) 2012 (2) (-) 2013 (2) 2014 (1) 2015 (5) 2016 (3) 2017 (4) 2018 (3) 2019 (3) 2020 (5) 2021 (4) 2022 (7) 2023 (6) 2024 (1) 8 Ergebnisse: Active Filter: Daniel, Peter Prof. Dr.Janz, Martin Dr.Leisegang, Matthias Prof. Dr. rer. nat.Biologie maligner LymphomeMolekulare Immunologie und Gentherapie 200220062013 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 23. Juli 2013 / Proc Natl Acad Sci U S A PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma M. Pfeifer M. Grau D. Lenze S.S. Wenzel A. Wolf B. Wollert-Wulf K. Dietze H. Nogai B. Storek H. Madle B. Dörken M. Janz S. Dirnhofer P. Lenz M. Hummel A. Tzankov G. Lenz 26. September 2013 / Blood IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL H. Nogai S.S. Wenzel S. Hailfinger M. Grau E. Kaergel V. Seitz B. Wollert-Wulf M. Pfeifer A. Wolf M. Frick K. Dietze H. Madle A. Tzankov M. Hummel B. Dörken C. Scheidereit M. Janz P. Lenz M. Thome G. Lenz
01. November 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
23. Juli 2013 / Proc Natl Acad Sci U S A PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma M. Pfeifer M. Grau D. Lenze S.S. Wenzel A. Wolf B. Wollert-Wulf K. Dietze H. Nogai B. Storek H. Madle B. Dörken M. Janz S. Dirnhofer P. Lenz M. Hummel A. Tzankov G. Lenz
26. September 2013 / Blood IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL H. Nogai S.S. Wenzel S. Hailfinger M. Grau E. Kaergel V. Seitz B. Wollert-Wulf M. Pfeifer A. Wolf M. Frick K. Dietze H. Madle A. Tzankov M. Hummel B. Dörken C. Scheidereit M. Janz P. Lenz M. Thome G. Lenz